Application of endoscopic nasobiliary cutting in the treatment of hilar cholangiocarcinoma

被引:0
|
作者
Shujuan Jiang [1 ]
Zhongyin Zhou [1 ]
机构
[1] Department of Gastroenterology,Renmin Hospital of Wuhan University
关键词
D O I
暂无
中图分类号
R735.8 [胆囊、胆道肿瘤];
学科分类号
摘要
Objective The aim of the study was to study the clinical efficacy and prognosis of endoscopically cutting the nasobiliary duct and leaving its residual segment as a biliary stent in the treatment of hilar cholangiocarcinoma (HC).Methods The clinical data of 55 patients with HC treated by endoscopic biliary drainage at the Gastrointestinal Endoscopy Center of our hospital (Renmin Hospital of Wuhan University,China) from August 2017 to August 2019 were retrospectively analyzed.According to different drainage schemes,patients were divided into the endoscopic nasobiliary cutting group (n=26) and the endoscopic retrograde biliary drainage (ERBD) group (n=29).The postoperative liver function indexes,incidence of postoperative complications,median patency period of stents,and median survival time of patients were compared between the two groups.Results Liver function indexes (total bilirubin,direct bilirubin,alanine aminotransferase,aspartate aminotransferase,alkaline phosphatase,gamma-glutamyl transpeptidase) were significantly decreased in 55 patients a week postoperaticely (P < 0.05),and decreases in liver function indexes in the endoscopic nasobiliary cutting group were more significant than those in the ERBD group (P < 0.05).The incidence of biliary tract infection in the endoscopic nasobiliary cutting group was significantly lower than that in the ERBD group (15.40% vs.41.4%,P < 0.05).In the endoscopic nasobiliary cutting subgroups,there were 1 and 3 cases of biliary tract infection in the gastric antrum cutting group (n=21) and duodenal papilla cutting group (n=5),respectively,and 0 cases and 2 cases of displacement,respectively;there was a statistically significant difference in terms of complications between the two subgroups (P < 0.05).The median patency period (190 days) and median survival time (230 days) in the nasobiliary duct cutting group were higher than those (169 days and 202 days) in the ERBD group,but there was no significant difference (P > 0.05).Conclusion The nasobiliary duct was cut by using endoscopic scissors in Stage II after the bile was fully drained through the nasobiliary duct.The residual segment could still support the bile duct and drain bile.The reduction of jaundice and the recovery of liver enzymes were significant,and the incidence of biliary tract infection was low.Cutting off the nasobiliary duct at the duodenal papilla results in a higher incidence of biliary tract infection,and the residual segment of the nasobiliary duct is more likely to be displaced.Endoscopic nasobiliary-cutting drainage is an effective,simple,and safe method to reduce jaundice in the palliative treatment of HC.
引用
收藏
页码:76 / 82
页数:7
相关论文
共 50 条
  • [41] AsiaPacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma
    Rerknimitr, Rungsun
    Angsuwatcharakon, Phonthep
    Ratanachu-ek, Thawee
    Khor, Christopher J. L.
    Ponnudurai, Ryan
    Moon, Jong Ho
    Seo, Dong Wan
    Pantongrag-Brown, Linda
    Sangchan, Apichat
    Pisespongsa, Pises
    Akaraviputh, Thawatchai
    Reddy, Nageshwar D.
    Maydeo, Amit
    Itoi, Takao
    Pausawasdi, Nonthalee
    Punamiya, Sundeep
    Attasaranya, Siriboon
    Devereaux, Benedict
    Ramchandani, Mohan
    Goh, Khean-Lee
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (04) : 593 - 607
  • [42] Oncological Superiority of Hilar En Bloc Resection for the Treatment of Hilar Cholangiocarcinoma
    Neuhaus, Peter
    Thelen, Armin
    Jonas, Sven
    Puhl, Gero
    Denecke, Timm
    Veltzke-Schlieker, Wilfried
    Seehofer, Daniel
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (05) : 1602 - 1608
  • [43] Oncological Superiority of Hilar En Bloc Resection for the Treatment of Hilar Cholangiocarcinoma
    Peter Neuhaus
    Armin Thelen
    Sven Jonas
    Gero Puhl
    Timm Denecke
    Wilfried Veltzke-Schlieker
    Daniel Seehofer
    Annals of Surgical Oncology, 2012, 19 : 1602 - 1608
  • [44] Multimodal treatment strategies for advanced hilar cholangiocarcinoma
    Weiss, Matthew J.
    Cosgrove, David
    Herman, Joseph M.
    Rastegar, Neda
    Kamel, Ihab
    Pawlik, Timothy M.
    LANGENBECKS ARCHIVES OF SURGERY, 2014, 399 (06) : 679 - 692
  • [45] Resection of the caudate lobe for the treatment of hilar cholangiocarcinoma
    Pinotti, Enrico
    Sandini, Marta
    Famularo, Simone
    Tamini, Nicolo
    Romano, Fabrizio
    Gianotti, Luca
    MINERVA CHIRURGICA, 2019, 74 (04) : 348 - 358
  • [47] Advances in diagnosis and treatment of hilar cholangiocarcinoma - a review
    Geng Zhimin
    Noor, Hidayatullah
    Jian-Bo, Zheng
    Lin, Wang
    Jha, Rajiv Kumar
    MEDICAL SCIENCE MONITOR, 2013, 19 : 648 - 656
  • [48] Multimodal treatment strategies for advanced hilar cholangiocarcinoma
    Matthew J. Weiss
    David Cosgrove
    Joseph M. Herman
    Neda Rastegar
    Ihab Kamel
    Timothy M. Pawlik
    Langenbeck's Archives of Surgery, 2014, 399 : 679 - 692
  • [49] Principles of surgical oncology in the treatment of hilar cholangiocarcinoma
    Jonas, S
    Neuhaus, P
    EUROPEAN CONGRESS I.H.P.B.A. "BUDAPEST 1999", 1999, : 121 - 124
  • [50] National guidelines for the diagnosis and treatment of hilar cholangiocarcinoma
    Dar, Faisal Saud
    Abbas, Zaigham
    Ahmed, Irfan
    Atique, Muhammad
    Aujla, Usman Iqbal
    Azeemuddin, Muhammad
    Aziz, Zeba
    Bhatti, Abu Bakar Hafeez
    Bangash, Tariq Ali
    Butt, Amna Subhan
    Butt, Osama Tariq
    Dogar, Abdul Wahab
    Farooqi, Javed Iqbal
    Hanif, Faisal
    Haider, Jahanzaib
    Haider, Siraj
    Hassan, Syed Mujahid
    Jabbar, Adnan Abdul
    Khan, Aman Nawaz
    Khan, Muhammad Shoaib
    Khan, Muhammad Yasir
    Latif, Amer
    Luck, Nasir Hassan
    Malik, Ahmad Karim
    Rashid, Kamran
    Rashid, Sohail
    Salih, Mohammad
    Saeed, Abdullah
    Salamat, Amjad
    Tayyab, Ghias-un-Nabi
    Yusuf, Aasim
    Zia, Haseeb Haider
    Naveed, Ammara
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (09) : 1018 - 1042